Pathogenic variants in the BRCA1 and BRCA2 genes, belonging to the category of DNA double-strand-break repair genes, place female carriers at risk of developing several malignancies, of which breast or ovarian cancers are the most significant [3]. This evidence concerns the gene BRCA1 and ovarian carcinoma.